Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multimodal Liquid Biopsy-Based Assay as a Pre-Screening Test Before Low Dose CT Thorax (LDCT) to Streamline Lung Cancer Screening in High-Risk Individuals

NCT07358715 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT07358715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07358715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multimodal Liquid Biopsy-Based Assay as a Pre-Screening Test Before Low Dose CT Thorax (LDCT) to Streamline Lung Cancer Screening in High-Risk Individuals
Lead sponsor
National University Hospital, Singapore
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2024
Completion date
December 31, 2028
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer screening, early lung cancer detection, high-risk populations, lung cancer, lung neoplasms